Perioperative circulating tumor cell detection: Current perspectives
نویسندگان
چکیده
منابع مشابه
Circulating Tumor Cells and Historic Perspectives
Prior to my involvement in the development of the first Food and Drug Administration (FDA)-approved capture device for CTCs, our laboratory’s researchwas involved with investigations of the signaling pathways in B lymphocytes.Wewere studying the mechanisms underlying induction of replication, differentiation, apoptosis, and cell cycle arrest when an important event took place at Stanford Univer...
متن کاملCirculating Tumor Cell Testing
Development of new anti-tumor drugs is time consuming and costly. Is there an effective pharmacodynamic biomarker able to predict early success or failure of a drug candidate in development? Ideally, fully validated and widely accepted biomarkers should be applied in the early stages of drug development, reducing the duration and cost of R&D activities, even as early as the pre-clinical phase. ...
متن کاملDetection of Circulating Tumor Cells
The increasing number of treatment options for patients with metastatic carcinomas has created an accompanying need for methods to determine if the tumor will be responsive to the intended therapy and to monitor its effectiveness. Ideally, these methods would be noninvasive and provide quantitative real-time analysis of tumor activity in a variety of carcinomas. Assessment of circulating tumor ...
متن کاملCirculating tumor cells (CTCs) in lung cancer: current status and future perspectives.
Primary lung cancer is the leading cause of cancer-related deaths in most industrialized countries, and it is important to detect and control metastases distant from the lungs for improvement of a patient's prognosis. Circulating tumor cells (CTCs) are tumor cells that are shed from the primary site and circulate in the peripheral blood, and recent studies have shown that CTCs can be useful cli...
متن کاملThe current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer
Urothelial carcinoma of the bladder (UCB) is a complex disease, which is associated with highly aggressive tumor biologic behavior, especially in patients with muscle-invasive and advanced tumors. Despite multimodal therapy options including surgery, radiotherapy and chemotherapy, UCB patients frequently suffer from poor clinical outcome. Indeed, the potential of diverse opportunities for moder...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Biology & Therapy
سال: 2016
ISSN: 1538-4047,1555-8576
DOI: 10.1080/15384047.2016.1167296